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ABSTRACT 
Background: Acute pancreatitis is one of the most common cause of abdominal 
pain. About 10to 20% of patients will progress to Severe Acute Pancreatitis (SAP) 
with a mortality rate of 6 to 10 %.Individual patient’s response to pancreatitis is 
highly variable. Because of this, it is of utmost importance to predict who is at the 
risk of developing severe pancreatitis as this will help to institute more intensive 
treatment. This will in turn improve the mortality. For this purpose various scoring 
systems are used. This study compares the strength of various prognostic factors in 
assessing the severity of acute pancreatitis. We also compared the sensitivity and 
specificity of various scoring systems in assessing the severity and mortality of 
acute pancreatitis. 
Methods: A prospective, observational, clinical and investigational study was 
carried out in 50 patients admitted with acute pancreatitis in Government Rajaji 
Hospital Madurai. Twelve individual parameters -Age, WBC count, RBS, Blood 
Urea,  S.Creatinine, PaO2, S.Calcium, S.LDH, S.bilirubin, S.Albumin,S.AST and 
S.ALT were assessed for their strength of association with severity of acute 
pancreatitis. Five scoring systems APACHE II, Ranson’s, Imrie’s, Bank’s, 
Pitchumani & Agarwal system were compared for their sensitivity and specificity 
for assessing the severity and mortality of acute pancreatitis. 
Results: Among the 50 patients 18 patients developed Severe Acute Pancreatitis 
(SAP) marked by evidence of end organ failure, local complications like 
psuedocyst, and /or prolonged ICU stay of more than 7 days. Among this 8 patients 
died. Among the individual parameters B.Urea,S.Creatinine,PaO2 and WBC count, 
Age,S.Calcium and S.LDH levels showed a significant association with severity of 
acute pancreatitis. APACHE II systems had a sensitivity of 77.78%  and specificity 
of  96.88% in predicting severity.Sensitivity and specificity of Ranson’s score was  
83.33% and  96.88%   respectively. Imrie’s score had a sensitivity of  55%  and 
specificity of 100% .Both Bank’s score and Pitchumani score had comparatively 
low sensitivity and specificity. 
Conclusion:APACHE II score and Ranson’s score are the best scoring systems in 
predicting the severity of acute pancreatitis.Among individual parameters Hypoxia, 
Acute renal failure, leukocytosis, advancing age ,hypocalcemia and increase in 
serum LDH levels were the factors significantly associated with Severe Acute 
Pancreatitis(SAP). 
 
   
INTRODUCTION 
 
 Acute pancreatitis is one of the most important cause of 
abdominal pain. Its incidence varies from 5-80 per 100000 
population59.  The clinical course of acute pancreatitis is usually 
mild and often resolves without sequele.  Between 10-20%14 patients 
experiences severe acute pancreatitis (SAP) attacks resulting in 
intense inflammatory response, a variety of local and systemic 
complications which can lead to prolonged hospital stay with 
significant morbidity and mortality.  The mortality ranges between 
6-10%64. 
          Individual patient’s response to pancreatitis is often variable 
and highly unpredictable.  But early recognition of a patient who is 
more likely to progress to Severe Acute Pancreatitis(SAP) is 
important because these patients may need more aggressive 
treatment including surgical interventions.  This will in turn translate 
into improved outcome. 
 This has led to the development of various biochemical 
markers and scoring system for predicting the severity of acute 
pancreatitis.  Several scoring systems has developed for this which 
includes Ranson’s, Imrie’s, Bank’s, Pitchumani and Agarwal etc.  
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Eventhough it was originally designed to predict the intensive care 
unit survival, Apache II system is also used for this purpose. An 
ideal predictive criteria should be simple, non invasive and 
quantitative and the assessment tests should be readily available at 
the time of diagnosis. 
 In this study we are analyzing the strength of various 
biochemical parameters in predicting the severity of acute 
pancreatitis and also comparing the accuracy of various scoring 
system in predicting the mortality and severity of acute pancreatitis. 
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AIM OF THE STUDY 
 
1. To compare the various scoring systems with Apache II in 
predicting the severity of acute pancreatitis. 
2. To analyze whether any single parameter as an Index of 
severity of acute pancreatitis. 
3. To compare our study with published literature world wide. 
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REVIEW OF LITERATURE 
Acute pancreatitis has been recognized since time 
immemorial and has been described as the most terrible of all 
calamities that occur in connection with the abdominal viscera36. In 
1889, Reginald Fitz gave the classic clinical and pathological 
description of acute pancreatitis37. 
The pancreas is a gland located in the upper, posterior 
abdomen and is responsible for insulin production (endocrine 
pancreas) and the manufacture and secretion of digestive enzymes 
(exocrine pancreas) leading to carbohydrate, fat, and protein 
metabolism. Approximately 80% of the gross weight of the pancreas 
supports exocrine function, while the remaining 20% is involved 
with endocrine function.  
As mentioned, the principal function of the exocrine pancreas 
is to make food-digesting enzymes. Enzymes are produced within 
the pancreatic acinar cells, packaged into storage vesicles called 
zymogens, and then released via the pancreatic ductal cells into the 
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pancreatic duct, where they are secreted into the small intestine to 
begin the metabolic process. 
The incidence of pancreatitis varies in different countries and 
depends on cause, e.g., alcohol, gallstones, metabolic factors, and 
drugs. The estimated incidence in the United States it is 40/100000 
population per year22. Worldwide, the incidence of acute pancreatitis 
ranges between 5 and 80 per 100,000 population, with the highest 
incidence recorded in the United States and Finland59. 
Race 
The hospitalization rates of patients with acute pancreatitis per 
100,000 population are 3 times higher for blacks than whites. These 
racial differences are more pronounced for males than females. 
Sex 
In general, acute pancreatitis affects males more often than 
females. 
The etiology in males is more often related to alcohol; in 
females, to biliary tract disease. 
Idiopathic pancreatitis has no clear predilection for either sex. 
Pancreatic inflammatory disease may be classified as1 
 (1)  Acute pancreatitis.  
5
   
 (2)  Chronic pancreatitis. 
 
 The pathologic classification1 
1. Interstitial pancreatitis, also called edematous pancreatitis which 
is usually a mild and self-limited disorder. 
2. Necrotizing pancreatitis, occurs in about 20%–30% of all 
patients with acute pancreatitis in which the degree of pancreatic 
necrosis correlates with the severity of the attack and its systemic 
manifestations. It is characterized by a protracted clinical course, a 
high incidence of local complications, and a high mortality rate. 
Parenchymal pancreatic injury is the pathologic hallmark of this 
form of the disease. 
Etiology and Pathogenesis 
There are many causes of acute pancreatitis but the 
mechanisms by which these conditions trigger pancreatic 
inflammation have not been identified. 
 Gallstones continue to be the leading cause of acute 
pancreatitis in most series (30–60%). 
 Alcohol is the second most common cause, responsible for 
15–30% of cases in the United States.  
6
   
Hypertriglyceridemia is the cause of acute pancreatitis in 
1.3–3.8% of cases; serum triglyceride levels are usually >11.3 
mmol/L (>1000 mg/dL). 
Acute pancreatitis occurs in 5–20% of patients following 
endoscopic retrograde cholangiopancreatography (ERCP).  
Approximately 2–5% of cases of acute pancreatitis are drug-
related. Drugs cause pancreatitis either by a hypersensitivity reaction 
or by the generation of a toxic metabolite, although in some cases it 
is not clear which of these mechanisms is operative.  
Drugs definitely associated with acute pancreatitis include 
azathioprine, sulfonamides, sulindac, tetracycline, valproic acid, 
didanosine, methyldopa, estrogens, furosemide, 6-mercaptopurine, 
pentamidine, 5-aminosalicylic acid compounds, corticosteroids, and 
octreotide. 
Infection (<1%):Viral causes include mumps, Epstein-
Barr,HIV, coxsackievirus, echovirus, varicella-zoster, and measles. 
Bacterial causes include Mycoplasma pneumoniae, Salmonella, 
Campylobacter, and Mycobacterium tuberculosis. 
Other Cause: 
Hereditary pancreatitis (< 1%) 
7
   
Hypercalcemia (< 1%) 
Developmental abnormalities of the pancreas (< 1%) 
Hypertriglyceridemia (< 1%) 
Toxins (<1%):Exposure to organophosphate insecticide can 
cause acute pancreatitis. 
Tumor (< 1%):Obstruction of the pancreatic ductal system by 
a pancreatic ductal carcinoma, ampullary carcinoma, islet cell tumor, 
solid pseudotumor of the pancreas, sarcoma, lymphoma, 
cholangiocarcinoma, or metastatic tumor can cause acute 
pancreatitis. 
Postoperative (< 1%) 
Vascular abnormalities (< 1%) 
Autoimmune pancreatitis (< 1%) 
In up to 10% of cases, the cause of pancreatitis remains 
unknown (idiopathic). 
Pancreatic Injury: Pathophysiology 
It has been assumed that the initial triggering event occurs at 
the cellular level and is based on premature activation of pancreatic 
enzymes leading to autodigestion of  the pancreatic parenchyma and 
peripancreatic tissues. The mechanism by which pancreatic enzymes 
8
   
are  activated outside the intestinal tract remains obscure. 
Intraparenchymal and extrapancreatic extravasation of these 
activated digestive enzymes is responsible for tissue injury and for 
damage to the pancreatic vascular network.  
 
 
. 
Pathologic examination of severe pancreatitis has shown 
extensive interstitial fat necrosis, necrotizing vasculitis with 
occlusions and thrombosis of small feeding arteries and draining 
veins, areas of hemorrhage, and devitalized pancreatic parenchyma. 
9
   
Similar findings are present in variable degrees in extrapancreatic 
retroperitoneal fatty tissue. 
Necrosis occurs early, within the first 24–48 hours, and it can 
be diffuse or patchy or superficial or deep, and it may affect any part 
of the pancreatic gland. 
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CLINICAL FEATURES 
Abdominal pain is the major symptom of acute pancreatitis. 
Pain may vary from a mild and tolerable discomfort to severe, 
constant, and incapacitating distress. Characteristically, the pain, 
which is steady and boring in character, is located in the epigastrium 
and periumbilical region and often radiates to the back as well as to 
the chest, flanks, and lower abdomen. The pain is frequently more 
intense when the patient is supine, and patients often obtain relief by 
sitting with the trunk flexed and knees drawn up.  
Nausea, vomiting, and abdominal distention due to gastric and 
intestinal hypomotility and chemical peritonitis are also frequent 
complaints. 
Physical examination  
Low-grade fever,  
Tachycardia,  
Hypotension,  
Jaundice occurs infrequently; when present, it usually is due to 
edema of the head of the pancreas with compression of the 
intrapancreatic portion of the common bile duct.  
11 
   
Erythematous skin nodules due to subcutaneous fat necrosis 
may occur. 
 In 10–20% of patients, there are pulmonary findings, 
including basilar rales, atelectasis, and pleural effusion, the latter 
most frequently left-sided.  
Abdominal tenderness and muscle rigidity are present to a 
variable degree, but, compared with the intense pain, these signs 
may be unimpressive.  
Bowel sounds are usually diminished or absent. An enlarged 
pancreas with organized necrosis or a pseudocyst may be palpable in 
the upper abdomen. 
 A faint blue discoloration around the umbilicus (Cullen's sign) 
may occur as the result of hemoperitoneum, and a blue-red-purple or 
green-brown discoloration of the flanks (Turner's sign) reflects tissue 
catabolism of hemoglobin. The latter two findings, which are 
uncommon, indicate the presence of a severe necrotizing 
pancreatitis. 
Laboratory Data 
The diagnosis of acute pancreatitis is usually established by 
the detection of an increased level of serum amylase. Values 
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threefold or more above normal virtually clinch the diagnosis if 
overt salivary gland disease and gut perforation or infarction are 
excluded. However, there appears to be no definite correlation 
between the severity of pancreatitis and the degree of serum amylase 
elevation. After 48–72 h, even with continuing evidence of 
pancreatitis, total serum amylase values tend to return to normal. 
However, pancreatic isoamylase and lipase levels may remain 
elevated for 7–14 days 
Serum lipase activity increases in parallel with amylase 
activity. Measurement of both enzymes is important as serum 
amylase tends to be higher in gallstone pancreatitis and serum lipase 
higher in alcohol-associated pancreatitis. A threefold elevated serum 
lipase value is usually diagnostic of acute pancreatitis; these tests are 
especially helpful in patients with nonpancreatic causes of 
hyperamylasemia. 
 Markedly increased levels of peritoneal or pleural fluid 
amylase [>1500 nmol/L (>5000 U/dL)] are also helpful, if present, 
in establishing the diagnosis. 
Leukocytosis (15,000–20,000 leukocytes per L) occurs 
frequently. Patients with more severe disease may show 
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hemoconcentration with hematocrit values >44% because of loss of 
plasma into the retroperitoneal space and peritoneal cavity. 
Hemoconcentration may be the harbinger of more severe disease, 
i.e., pancreatic necrosis. 
  Hyperglycemia is common and is due to multiple factors, 
including decreased insulin release, increased glucagon release, and 
an increased output of adrenal glucocorticoids and catecholamines.  
       Hypocalcemia occurs in ~25% of patients, and its pathogenesis 
is incompletely understood.  
Hyperbilirubinemia [serum bilirubin > 68 mol/L (>4.0 
mg/dL)] occurs in ~10% of patients. However, jaundice is transient, 
and serum bilirubin levels return to normal in 4–7 days. 
 Serum alkaline phosphatase and aspartate aminotransferase 
(AST) levels are also transiently elevated and parallel serum 
bilirubin values.  
Markedly elevated serum lactic dehydrogenase (LDH) levels 
[>8.5 mol/L (>500 U/dL)] suggest a poor prognosis.  
Serum albumin is decreased to 30 g/L (3.0 g/dL) in ~10% of 
patients; this finding is associated with more severe pancreatitis and 
a higher mortality rate. 
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  Hypertriglyceridemia occurs in 15 to 20% of patients, and 
serum amylase and lipase levels in these individuals are often 
spuriously normal.  
Approximately 25% of patients have hypoxemia (arterial PO2 
<60 mmHg), which may herald the onset of ARDS. 
Abdominal ultrasonography 
This is the most useful initial test in determining the etiology 
of pancreatitis and is the technique of choice for detecting gallstones.  
Abdominal CT scanning 
This is generally not indicated for patients with mild 
pancreatitis unless a pancreatic tumor is suspected (usually in elderly 
patients). 
CT scanning is always indicated in patients with severe acute 
pancreatitis and is the imaging study of choice for assessing 
complications. 
Abdominal CT scans also provide prognostic information 
based on the following grading scale developed by Balthazar17: 
A  - Normal 
B  -  Enlargement  
C  -  Peripancreatic inflammation 
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D  -  Single fluid collection 
E  -  Multiple fluid 
The chances of infection and death are virtually nil in grades A 
and B but steadily increase in grades C through E. Patients with 
grade E pancreatitis have a 50% chance of developing an infection 
and a 15% chance of dying. 
Magnetic resonance cholangiopancreatography 
Heavily T-2–weighted images provide a noninvasive image of 
the biliary and pancreatic ducts. Although not as sensitive as ERCP, 
MRCP is safer, noninvasive, and fast, and it provides images useful 
in guiding clinical care decisions. This modality should be used if 
choledocholithiasis is suspected. 
Diagnosis 
Any severe acute pain in the abdomen or back should suggest 
acute pancreatitis. The diagnosis is usually entertained when a 
patient with a possible predisposition to pancreatitis presents with 
severe and constant abdominal pain, nausea, emesis, fever, 
tachycardia, and abnormal findings on abdominal examination. 
Laboratory studies frequently reveal leukocytosis, hypocalcemia, 
and hyperglycemia. The diagnosis is usually confirmed by the 
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finding of a threefold or greater elevated level of serum amylase 
and/or lipase.  
Acute Pancreatitis: Treatment 
In most patients (85–90%) with acute pancreatitis, the disease 
is self-limited and subsides spontaneously, usually within 3–7 days 
after treatment is instituted. 
 Conventional measures include (1) analgesics for pain, (2) IV 
fluids and colloids to maintain normal intravascular volume, and (3) 
no oral alimentation. 
Nasogastric suction offers no clear-cut advantages in the 
treatment of mild to moderately severe acute pancreatitis.It has been 
demonstrated that CCK-stimulated pancreatic secretion is almost 
abolished in four different experimental models of acute pancreatitis. 
This finding probably explains why drugs to block pancreatic 
secretion in acute pancreatitis have failed to have any therapeutic 
benefit. For this and other reasons, anticholinergic drugs are not 
indicated in acute pancreatitis.  
Total parentral nutrition / artificial nutrition 
Where it is feasible and when enteral nutrition is 
contraindicated, use of amino acid infusion about 1-1.5 g/kg/day and 
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the use of intravenous lipids, unless contraindicated by elevated 
triglyceride levels, in several cases especially in sepsis cases has 
helped to decrease morbidity and mortality. Recent studies on 
intensive care patients with trauma and sepsis showed that enteral 
feeding was associated with a reduction in the acute phase response 
and the severity of septic complications compared to total parentral 
nutrition . A clear liquid diet is frequently started on the third to 
sixth day and a regular diet by the fifth to seventh day. The decision 
to reintroduce oral intake is usually based on the following criteria: 
(1) a decrease in or resolution of abdominal pain; (2) the patient is 
hungry; and (3) organ dysfunction, if present, has resolved. 
Elevation of serum amylase/lipase or persistent inflammatory 
changes seen on CT scans should not discourage feeding a hungry 
asymptomatic patient. 
Role of Antibiotics 
The benefit of antibiotic prophylaxis in the treatment of 
necrotizing acute pancreatitis remains controversial. Although the 
optimal drugs and duration of therapy remain incompletely defined, 
the current recommendation in patients with necrotizing acute 
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pancreatitis is the use of a systemic antibiotic such as Imipenem- 
Cilastin, 500 mg thrice daily for 7 days.  
Several other drugs have been evaluated by prospective 
controlled trials and found ineffective in the treatment of acute 
pancreatitis. These drugs includes glucagon, H2 blockers, protease 
inhibitors such as aprotinin, glucocorticoids, calcitonin, nonsteroidal 
anti-inflammatory drugs (NSAIDs), and lexipafant, a platelet-
activating factor inhibitor. 
  A recent meta-analysis of somatostatin, octreotide, and the 
antiprotease gabexate mesylate in therapy of acute pancreatitis 
suggested (1) a reduced mortality rate but no change in 
complications with octreotide, and (2) no effect on the mortality rate 
but reduced pancreatic damage with gabexate. 
SURGICAL TREATMENT 
Most patients with acute pancreatitis do not require surgical 
treatment of the pancreatic disease although many will subsequently 
undergo cholecystectomy. 
Indications for intervention in pancreatic necrosis8 
The decision to intervene depends on the clinical picture 
(evidence of sepsis) and demonstration by CT of pancreatic or 
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peripancreatic necrosis. There is agreement that all patients with 
infected necrosis require intervention by radiological or surgical 
drainage.The infection may be diagnosed either by the presence of 
gas within the pancreatic collection or by fine needle aspiration. 
Patients with infected necrosis will require intervention to 
completely debride all cavities containing necrotic material. 
Radiological drainage8 
In one report, 31 patients with pancreatic abscess were 
managed by percutaneous drainage. There was a 31% primary 
success rate. Freeny et al also reported encouraging results: in 34 
patients nearly half had successful treatment by catheter drainage 
and only nine required surgical drainage. This suggests that 
percutaneous wide bore drainage may be sufficient for the treatment 
of infected necrosis. 
COMPLICATIONS1 
Local Complications 
Necrosis 
  1. Sterile 
  2. Infected 
  3. Organized 
20
   
Pancreatic fluid collections 
Pancreatic abscess 
Pancreatic pseudocyst : This is a collection of pancreatic fluid 
enclosed by a wall of granulation tissue and requires 4 or more 
weeks to develop.Complications of Psuedocyst includes: 
  1. Pain 
     2.Rupture 
     3.Hemorrhage 
    4. Infection 
    5. Obstruction of gastrointestinal tract (stomach, duodenum, colon) 
Pancreatic ascites : which could be due to 
     1.Disruption of main pancreatic duct 
     2.Leaking pseudocyst  
Involvement of contiguous organs by necrotizing pancreatitis  
    1. Massive intraperitoneal hemorrhage 
     2.Thrombosis of blood vessels (splenic vein, portal vein) 
    3. Bowel infarction 
4.Obstructive jaundice 
Intra-abdominal infections 
Within the first 1-3 weeks, fluid collections or pancreatic 
necrosis can become infected and jeopardize clinical outcome. 
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From 3-6 weeks, pseudocysts may become infected or a 
pancreatic abscess may develop. 
  A pancreatic abscess is a circumscribed intra-abdominal 
collection of pus, within or in proximity to the pancreas. It is 
believed to arise from localized necrosis, with subsequent 
liquefaction that becomes infected. 
Pancreatic necrosis 
This is a nonviable area of pancreatic parenchyma that is often 
associated with peripancreatic fat necrosis and is principally 
diagnosed with the aid of dynamic spiral CT scans. Sterile pancreatic 
necrosis is usually treated with aggressive medical management, 
whereas almost all patients with infected pancreatic necrosis require 
surgical debridement or percutaneous drainage if they are to survive. 
Systemic Complications 
Pulmonary:  
                   :Pleural effusion,Atelectasis, Pneumonitis, 
                   :Adult respiratory distress syndrome, 
          :Mediastinal abscess. 
Cardiovascular: 
:Hypotension, Hypovolemia, Sudden death, 
: Pericardial effusion, 
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                     :Nonspecific ST-T changes in electrocardiogram  
                     simulating myocardial  infarction . 
Hematologic : 
:Disseminated intravascular coagulation. 
Gastrointestinal : 
         :Peptic ulcer disease,Erosive gastritis, 
         :Hemorrhagic pancreatic necrosis with erosion in to major  
          blood vessels, 
           :Portal vein thrombosis, variceal hemorrhage 
Renal :      
: Oliguria,Azotemia, Acute tubular necrosis, 
                     :Renal artery and/or renal vein thrombosis 
Metabolic:   
:Hyperglycemia,Hypertriglyceridemia,  Hypocalcemia, 
:Encephalopathy, 
   : Sudden blindness (Purtscher's retinopathy) 
Central nervous system: 
                      :  Psychosis,  Fat emboli 
Fat necrosis: Subcutaneous tissues (erythematous nodules) 
Mortality/Morbidity 
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The overall mortality rate of patients with acute pancreatitis is 
10-15%. This rate has been falling over the last two decades as 
improvements in supportive care have been initiated. 
In patients with severe disease (organ failure), the mortality 
rate is approximately 30%. This rate in mortality has not dropped in 
the last 10 years. 
In the first week of illness, most deaths result from multiorgan 
system failure. In subsequent weeks, infection plays a more 
significant role, but organ failure still constitutes a major cause of 
mortality. 
Multiple Prognostic Indices 
Once the diagnosis of acute pancreatitis is established, the 
treatment of patients depends on the early assessment of disease 
severity. This assessment, based on objective parameters, is crucial 
for predicting clinical complications and for identifying potentially 
lethal attacks.  
For many years, it has been recognized that obvious alterations 
of clinical parameters and some abnormal results of routine 
laboratory tests are often present in patients with severe pancreatitis. 
For instance, a low serum calcium level (7.5 mg/dL [1.88 mmol/L]) 
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detected in the background in cases of an acute attack of pancreatitis 
is a worrisome sign that is seen mainly in patients with severe 
disease 17.Furthermore, it has been shown that the risk of death is 
increased in patients in whom the serum glucose level is above 250 
mg/dL (13.9 mmol/L) and the serum creatinine level after 
rehydration is above 2 mg/dL (177 mmol/L)17. Signs of multiorgan 
failure and some specific abnormal clinical and laboratory findings 
can help identify patients with a severe, potentially lethal form of 
disease. The presence of one or several signs of distal organ failure 
was associated with a 50% mortality rate in the series of Bank et al. 
None of the individual clinical or laboratory parameters, while 
useful in clinical practice, are sufficiently sensitive or specific to 
help identify most patients with necrotizing pancreatitis. 
In the attempt to overcome these deficiencies, various scoring 
systems that combine clinical and laboratory parameters have been 
devised to help identify patients with severe pancreatitis. These 
scoring systems use the number of specific abnormalities, called 
prognostic signs, grave signs, risk factors, or objective indicators, to 
stage acute pancreatitis. It should be emphasized that these 
physiologic alterations reflect systemic abnormalities; they do not 
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correlate well with severity and extent of local disease, and they 
certainly do not have diagnostic specificity, because they can be seen 
in a variety of other conditions. 
The first numeric system, proposed by Ranson et al  in 197429 
(Ranson system), is still the most widely used. Originally, the 
Ranson score was created from a retrospective review of one 
institution’s experience with pancreatitis. The authors examined 43 
variables from 100 consecutive patients with pancreatitis and found 
11 different variables that correlated with subsequent mortality and 
morbidity. 
 It is based on 11 objective signs: five determined initially, and 
six within 48 hours. With an increased number of risk factors, there 
is a corresponding increase in the morbidity and mortality rates. In 
patients with fewer than three positive signs, there is no mortality, 
three or more than three positive signs have increased mortality, 
while in patients with six or more signs the mortality rate is over 
50%. Individuals with more than six grave signs usually have 
necrotizing pancreatitis. 
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At admission: 
 
1. Age in years > 55 years 
    2.  White blood cell count > 16000 cells/mm3           
3. Blood glucose > 10 mmol/L (> 200 mg/dL)     
4. Serum AST > 250 IU/L        
5. Serum LDH > 350 IU/L 
At 48 hours: 
1. Calcium (serum calcium < 2.0 mmol/L (< 8.0 mg/dL) 
2. Hematocrit fall > 10%   
3. Oxygen (hypoxemia PO2 < 60 mmHg)  
4. BUN increased by 1.8 or more mmol/L (5 or more mg/dL) after IV 
fluid hydration.         
5. Base deficit (negative base excess) > 4 mEq/L 
6. Sequestration of fluids > 6 L 
 
Although the Ranson score has been widely purported to be a 
valid measure of outcome, it was never validated prospectively by its 
creators or tested in any type of large multicenter trial subsequent to 
its inception. Others disadvantage is that even if the Ranson score 
were an accurate predictor, a 48-hour period is required before the 
total score can be tabulated. 
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Alternative grading systems, each using different parameters, 
have since been constructed, with a prognostic capability generally 
similar to that of the Ranson system. The Glasgow original or 
modified system, the Simplified Acute Physiology or SAP, score, 
and simplified prognostic criteria have been used. 
Blamey et al introduced a modification of the Ranson 
system19, based on eight prognostic criteria. They omitted hematocrit 
level, base deficit, age, and fluid sequestration but included serum 
albumin level of less than 32 g/L as an important criterion of 
severity. Despite modifications and fine tuning, however, the overall 
sensitivity of the aforementioned numeric systems in the initial 
staging of an attack of pancreatitis ranges from 57% to 85%, with a 
specificity of 68%–85% . 
Modified Glasgow system by Imrie  :    
 A score >3 suggestive of SAP 
During Initial 48 hours 
WBC count >15 x 10^9/L (15 x 10^3/microlitre)  
Serum albumin <32 g/L (3.2 g/dL)  
Arterial PO2 on room air <8 kPa (60 mmHg)  
Serum calcium <2 mmols/L (8 mg/dL)  
Blood glucose >10.0 mmols/L (180 mg/dL)  
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Serum LDH >600 units/L  
Serum urea nitrogen >16.1 mmols/L (45 mg/dL)  
ALT/AST>200 U/L 
Severe Acute Pancreatitis (SAP) as Defined by Atlanta Symposium 
The International Symposium, held in Atlanta, in 1992, 
established a clinically based classification system for acute 
pancreatitis. According to the Atlanta Symposium, acute pancreatitis 
was defined as an acute inflammatory process of the pancreas that 
may also involve peripancreatic tissues and/or remote organ systems. 
Criteria for severity included organ failure (particularly shock, 
pulmonary insufficiency, and renal failure) and/or local 
complications (especially pancreatic necrosis but also including 
abscess and pseudocyst). Early predictors of severity within 48 h of 
initial hospitalization included Ranson signs and APACHE-II points 
Early Prognostic Signs 
Ranson signs ≥3 
APACHE-II score ≥8 
Organ Failure marked by 
1. Shock–systolic pressure <90 mmHg 
2. PaO2 ≤60 mmHg 
3. Creatinine >2.0 mg/L after rehydration 
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4. Gastrointestinal bleeding >500 cc/24 h 
And/Or 
Local Complications 
1. Necrosis 
2. Abscess 
3. Pseudocyst 
More recently, the Acute Physiology and Chronic Health 
Evaluation (APACHE II) assessment and monitoring system has 
become popular, because it is considered to be more reliable41.The 
acute physiology score and the chronic health evaluation (APACHE) 
were used in the first major attempts to quantify the severity of the 
illness in ICU patients, by Knaus et al in 1981 and this was later 
modified in 1985 by the same author as APACHE II39,40 
It contains 12 continuous variables from the original APACHE 
system and also takes into account the age of the patient, the pre-
morbid conditions and the Glasgow coma scale (GCS). The major 
advantage of the APACHE II scoring system, as compared to the 
other systems, is that it can be used in monitoring the patient’s 
response to therapy while the Ranson and the Glasgow scales are 
mainly meant for the assessment at presentation . 
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The APACHE II scoring system takes into account 12 
variables which include, (1) Body temperature, (2) mean arterial 
pressure (mm Hg), (3) Heart rate(HR), (4) respiratory rate (R.R/mt), 
(5) Oxygenation (mm Hg), (6) PH, (7) Na+ (mmol/l), (8) K+ 
(mmol/l), (9) Creatinine (mg/dl), (10) Haematocrit, (11) total 
leucocyte count and the (12) Glasgow coma score. 
  To eliminate the problem of the missing values and concerns 
about the assumption that an unmeasured variable was normal, the 
measurement of all the 12 variables was made mandatory for the 
usage of APACHE II. The recorded values of the variables are based 
on the most derange values during the past 24 hours .Because age 
and severe chronic health problems reflects diminished physiological 
reserve, they have been directly incorporated into  
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APACHE II 
 
 
+ 4 +3 +2 +1 0 +1 +2  +3  +4 
1   Rectal temp (◦C)  >41 39–40.9 38–38.9 36–38.4 34–35.9 32–33.9 30–31.9 <29.9
2   Mean arterial pressure 
(mmHg)  
>160 130–159 110–129  70–109  50–69   <49 
3   Heart rate (bpm)  >180 140–179 110–139 70–109 55–69 40–54 <39
4   Respiratory rate (bpm)  >50 35–49  25–34 12–24 10–11 6–9   <5 
5   Oxygen delivery 
(mL/min)  
>500 350–499 200–349  <200     
6   PO2 (mmHg)   >70 61–70 55–60 <55
7   Arterial pH  >7.7 7.6–7.69  7.5–7.59 7.3–7.49  7.25–7.3 7.15–7.2 <7.15 
8   Serum sodium (mmol/L)  >180 160–179 155–159 150–154 130–149 120–129 111–119 <110
9   Serum potassium 
(mmol/L)  
>7 6–6.9  5.5–5.9 3.5–5.4 3–3.4 2.5–2.9   <2.5 
10 Serum creatinine 
(mg/dL)  
>3.5 2–3.4 1.5–1.9  0.6–1.4  <0.6    
11   Hematocrit (%)  >60 50–59.9 46–49.9 30–45.9 20–29.9 <20
12   White cell count   
(103/mL)  
>40  20–39.9 15–19.9 3–14.9  1–2.9   <1 
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   Age Points       
Age          Points 
<44          0 
45–54          2 
55–64          3 
65–74          5 
>75          6 
 Chronic Health Points  
History of Severe Organ 
Insufficiency 
 
Points 
Nonoperative patients  5 
Emergency postoperative 
patients 
 5 
Elective postoperative 
patients 
 
2 
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The system is complex and more difficult to perform, because 
12 physiologic measurements are used. The higher the total score, 
the more severe the pancreatitis, with a corresponding increase in 
morbidity and mortality. It has been suggested that a cutoff 
APACHE II score of greater than 8 indicates severe pancreatitis. The 
major advantage of the APACHE II numeric system, as compared 
with the other systems, is that it can be used throughout the patient’s 
hospital course in monitoring the patient’s response to therapy .The 
accuracy of the APACHE II system at admission for the assessment 
of the severity of pancreatitis has been about 75%. The test is useful 
as an early prognostic indicator of disease severity to help identify 
patients for intensive care unit treatment. After 48 hours, APACHE 
II scores are comparable with Ranson system scores in 
distinguishing mild from severe pancreatitis, with an accuracy of 
about 70%–80% . 
CT Severity Index17 
The CT severity index is an attempt to improve the early 
prognostic value of CT in cases of acute pancreatitis. Patients with 
grade A–E pancreatitis are assigned zero to four points plus two 
points for necrosis of up to 30%, four points for necrosis of 30%–
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50%, and six points for necrosis of more than 50%. For instance, a 
patient with CT grade D is assigned three points; if, in addition, the 
patient has more than 50% necrosis, an additional six points are 
assigned, for a total index score of 9. There was a statistically 
significant correlation, with a continuous increasing incidence of 
morbidity and mortality in patients stratified according to CT 
severity index groups. Patients who had a severity index of 0 or 1 
exhibited a 0% mortality rate and no morbidity, while patients with 
severity index of 2 had no mortality and a 4% morbidity rate. In 
contrast, a severity index of 7–10 yielded a 17% mortality  rate and a 
92% complication rate . 
One of the other most commonly used scoring system is 
Banks System27 
 A score of ≥ 1 suggestive of SAP 
 Cardiac   - Shock / tachycardia > 130, arrhythmia 
 Pulmonary - Dyspnoea,  PaO2 < 60 mm, ARDS 
 Renal - Urine output < 50 ml / hr, Rising blood  
    urea / Creatinine 
 Metabolic - Low or falling calcium, pH, albumin  
    decrease 
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 Hematological - Falling PCV, DIC 
 Neurological - Irritability, confusion, localizing signs 
 Hemorrhagic - On signs or peritoneal tap 
 Tense distention - Severe ileus, fluid ++ 
Pitchumani and Agarwal28 
 A score ≥1 suggestive of SAP 
During initial 48 hrs 
 Cardiac  -  BP < 90 mmHg / tachycardia > 130 BPM 
 Pulmonary -  PO2 < 60 mm Hg 
 Renal  -  Urine output < 50 ml / min 
 Metabolic -  Calcium < 8 mg / dl or and albumin < 3.2 g/dl 
The newer biomarkers  in predicting the severity includes various  
cytokines like IL-1,IL-6,IL-8,IL-10 and TNF-alpha.Various pancreatic 
products like lipase,procarboxypeptidases,pancreatitis associated  peptide, 
trypsinogen 2 are also under study74.             
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MATERIALS AND METHODS 
 Place of study : Dept. of General Medicine 
     Govt. Rajaji Hospital, attached to 
     Madurai Medical College, Madurai. 
 Type of study : Prospective, Observational, Clinical  
     and Investigational study. 
 Ethical Committee: Ethical committee approval obtained. 
 Collaborating Department: Dept.of Medical  
      Gastroenterology 
 Period of Study : From September 2010 to August 2011
     
 Financial Support : Nil 
 Conflict of Interest: Nil 
Selection and Details of study subjects : 
 In this study, 50 patients admitted to Medicine / Medical 
Gastroenterology / Surgery and Surgical Gastroenterology wards of 
Govt. Rajaji Hopsital, Madurai with acute pancreatitis was included 
randomly. 
Inclusion Criteria : 
 The diagnosis of acute pancreatitis was based on 
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1. Clinical criteria :   History of abdominal pain radiating to 
back and relieved by bending forward and associated with 
tenderness and guarding of upper abdomen. 
2. Radiographic evidence 
 CT / USG findings suggestive of acute pancreatitis like 
pancreatic edema, pancreatic necrosis, peripancreatic fluid 
collection. 
3. Biochemical 
 Serum Amylase greater than 3 times of normal 
Exclusion criteria : 
1. All those patients with chronic pancreatitis were excluded. 
2. All the previously treated patients were excluded from our 
study. 
METHODOLOGY 
 History taking and physical examinations was done in all 
patients.  Physical examination included assessment of Glasgow 
coma scale, heart rate, blood pressure, mean arterial pressure, 
temperature, respiratory rate. 
 The following investigations were carried out 
1. Packed cell volume  (PCV) 
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2. Total WBC count (TC) 
3. Platelet counts (PLC) 
4. Random blood sugar (RBS) 
5. Blood urea 
6. Serum creatinine 
7. Serum bilirubin 
8. Alaline aminotransferase (ALT) 
9. Aspartate Aminotransferase (AST) 
10. Serum calcium (S.Ca++) 
11. Serum Lactate Dehydrogenase (S.LDH) 
12. Pa O2 
13. Base Deficit: measured as 24 minus serum Bicarbonate 
level 
14. Fluid Sequesteration 
Based on these clinical and investigational parameters patients 
were assigned scores according to Apache II, Ranson’s, Bank’s 
Imries, Pitchumani and Agarwal scoring systems using data’s from 
the first 48 hrs. 
Ranson’s Score: ≥3 was taken as predictor of severe pancreatitis 
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At admission: 
1. Age in years > 55 years 
2.  White blood cell count > 16000 cells/mm3          
3. Blood glucose > 10 mmol/L (> 200 mg/dL)    
4. Serum AST > 250 IU/L       
5. Serum LDH > 350 IU/L 
At 48 hours: 
1. Calcium (serum calcium < 2.0 mmol/L (< 8.0 mg/dL) 
2.. Hematocrit fall > 10%   
3. Oxygen (hypoxemia PO2 < 60 mmHg)  
4. BUN increased by 1.8 or more mmol/L (5 or more mg/dL) 
after IV fluid hydration.       
5. Base deficit (negative base excess) > 4 mEq/L 
6. Sequestration of fluids > 6 L 
Imries  :   A score >3 suggestive of SAP 
During Initial 48 hours 
1. WBC count >15 x 10^9/L (15 x 10^3/microlitre)  
2. Serum albumin <32 g/L (3.2 g/dL)  
3. Arterial PO2 on room air <8 kPa (60 mmHg)  
4. Serum calcium <2 mmols/L (8 mg/dL)  
5. Blood glucose >10.0 mmols/L (180 mg/dL)  
6. Serum LDH >600 units/L  
7. Serum urea nitrogen >16.1 mmols/L (45 mg/dL)  
8. ALT/AST>200 U/L 
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Banks System2   : A score of ≥ 1 suggestive of SAP 
 Cardiac   - Shock / tachycardia > 130, arrhythmia 
 Pulmonary - Dyspnoea,  PaO2 < 60 mm, ARDS 
 Renal - Urine output < 50 ml / hr, Rising blood  
    urea / Creatinine 
 Metabolic - Low or falling calcium, pH, albumin  
    decrease 
 Hematological- Falling PCV, DIC 
 Neurological- Irritability, confusion, localizing signs 
 Hemorrhagic- On signs or peritoneal tap 
 Tense distention- Severe ileus, fluid ++ 
Pitchumani and Agarwal28  : A score ≥1 suggestive of SAP 
During initial 48 hrs 
 Cardiac   -  BP < 90 mmHg / tachycardia > 130 BPM 
 Pulmonary -  PO2 < 60 mm Hg 
 Renal   - Urine output < 50 ml / min 
 Metabolic  -  Calcium < 8 mg / dl or and albumin < 3.2 g/dl 
 
 
41
   
APACHE II Score > 8 suggestive of SAP 
 
 
+4 +3  +2  +1  0  +1  +2  +3  +4  
1  Rectal temp (◦C)  >41 39–40.9 38–38.9 36–38.4 34–35.9 32–33.9 30–31.9 <29.9 
2  Mean arterial pressure 
(mmHg)  
>160 130–159 110–129  70–109   50–69   <49 
3  Heart rate (bpm)  >180 140–179 110–139 70–109 55–69 40–54 <39 
4  Respiratory rate (bpm)  >50  35–49   25–34  12–24  10–11  6–9   <5 
5  Oxygen delivery 
(mL/min)  
>500 350–499 200–349  <200     
6  PO2 (mmHg)   >70  61–70 55–60 <55 
7  Arterial pH  >7.7 7.6–7.69  7.5–7.59  7.3–7.49  7.25–7.3  7.15–7.2 <7.15 
8  Serum sodium (mmol/L)  >180 160–179 155–159 150–154 130–149 120–129 111–119 <110 
9  Serum potassium 
(mmol/L)  
>7  6–6.9   5.5–5.9  3.5–5.4  3–3.4  2.5–2.9   <2.5 
10 Serum creatinine 
(mg/dL)  
>3.5 2–3.4  1.5–1.9   0.6–1.4   <0.6   
11 Hematocrit (%)  >60 50–59.9 46–49.9 30–45.9 20–29.9 <20 
12 White cell count 
(103/mL)  
>40   20–39.9  15–19.9  3–14.9   1–2.9   <1 
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   Age 
Points 
      
Age         Points
<44         0 
45–54         2 
55–64         3 
65–74         5 
>75         6 
 
Chronic Health Points 
 
History of Severe Organ 
Insufficiency 
 Points 
Nonoperative patients  5 
Emergency postoperative 
patients 
 5 
Elective postoperative patients  2 
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For assessing the predictive accuracy of individual parameters 
the following cut-off values were fixed. 
1. Packed cell volume  (PCV) >44(As suggested by Atlanta 
symposium) 
2. Total WBC count (TC) > 15000 cells/cumm(Imries 
criteria) 
3. Age >55 (Imries criteria) 
4. Random blood sugar (RBS) > 200mg/dl(Imries criteria) 
5. Blood urea >45mg/dl(Imries criteria) 
6. Serum creatinine >2 mg/dl 
7. Serum bilirubin > 2mg/dl 
8. Alaline aminotransferase (ALT) >200U/L (Imries 
criteria) 
9. Aspartate Aminotransferase (AST) >200 U/L (Imries 
criteria) 
10. Serum calcium (S.Ca++) <8 mg/dl(Imries criteria) 
11. Serum Lactate Dehydrogenase (S.LDH) >350units/L 
(Ransons Criteria) 
12. Pa O2<60 mm Hg(Imries criteria) 
 
All these patients were followed up until death / discharge.  
Severe acute pancreatitis is defined by the presence of organ failure 
(shock, pulmonary insufficiency and renal failure) and/or local 
complications especially pancreatic necrosis but also psuedocyst or 
abscess or ICU stay of more than 7 days. 
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      12 individual parameters which are used in these scoring systems 
were assessed for their accuracy in predicting mortality / severity by 
calculating ‘p’ values. Base deficit and Fluid Sequestration was not 
assessed for their predictive accuracy as they were used only in a 
single scoring system ie Ransons scoring system 
 The sensitivity, specificity, positive predictive value and 
negative predictive values were calculated using the following 
formulas. 
 Sensitivity  =    True positive 
     True positive + False Negative 
 Specificity  =    True Negative 
     True Negative + False Positive 
 Positive predictive value =    True Positive 
      True Positive + False Positive 
 Negative predictive value =    True negative 
      True Negative + False Negative 
Statistical Tools   
The information collected regarding all the selected cases were 
recorded in a Master Chart. Data analysis was done with the help of 
computer using Epidemiological Information Package (EPI 2010) 
developed by Centre for Disease Control, Atlanta.  
 Using this software range, frequencies, percentages, means, 
standard deviations, chi square and  'p'  values were calculated by One 
way ANOVA and ‘t’ test. Kruskul Wallis chi-square  test was used to test 
the significance of difference between quantitative variables and Yate’s 
chi square test for qualitative variables.  
A 'p' value less than 0.05 is taken to denote significant relationship. 
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                                               RESULTS 
 
 
                                              TABLE – 1  
                                       AGE VS SEVERITY 
 
Age  Death SAP MILD 
< 55  (35) 4 5 26 
> 55  (15) 4 5 6 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.046   -  Significant 
Age > 55 years is significantly associated with an increased 
mortality & severity 
 
TABLE – 2 
TC VS SEVERITY 
 
Tc Death SAP MILD 
< 15000 (41) 2 7 32 
> 15000 (9) 6 3 0 
 
Death + SAP  Vs  Survival    ‘p’ value  =  < 0.001   -  Significant 
Leukocytosis > 15000cells/cmm  is found to have statistically 
significant association with mortality and severity. 
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TABLE – 3 
RBS VS SEVERITY 
 
RBS Death SAP MILD 
< 180(41) 5 7 29 
> 180 (9) 3 3 3 
 
         Death + SAP  Vs  Survival    ‘p’ value  =  0.083   -  Not 
Significant 
With a cut off value of 180 mg/dl the difference in the RBS 
levels between two groups (Death+SAP Vs Mild) were not 
statistically significant. 
 
TABLE – 4  
ALBUMIN VS SEVERITY 
 
ALBUMIN Death SAP MILD 
< 3.2 (9) 3 2 4 
> 3.2  (41) 5 8 28 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.334   -  Not 
Significant 
With a cut off value of 3.2 mg/dl the difference in the Albumin 
levels between two groups (Death+SAP Vs Mild) were not 
statistically significant. 
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TABLE – 5  
SERUM CALCIUM VS SEVERITY 
 
Sr. Cal  Death SAP MILD 
< 8  (13) 5 3 5 
> 8  (37) 3 7 27 
 
           Death + SAP  Vs  Survival    ‘p’ value  =  0.048   -  
Significant 
Serum Calcium>8 mg/dl is found to have statistically 
significant association with mortality and severity. 
 
TABLE – 6  
AST VS SEVERITY 
 
AST Death SAP MILD 
< 200 (42) 5 9 28 
> 200  (8) 3 1 4 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.618   -  Not 
Significant 
With a cut off value of 200U/Lthe difference in the AST levels 
between two groups (Death+SAP Vs Mild) were not statistically 
significant. 
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TABLE – 7 
ALT VS SEVERITY 
ALT Death SAP MILD 
< 200 (42) 5 9 28 
> 200  (8) 3 1 4 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.618   -  Not 
Significant 
With a cut off value of 200U/L the difference in the ALT levels 
between two groups (Death+SAP Vs Mild) were not statistically 
significant. 
 
TABLE – 8  
UREA VS SEVERITY 
 
UREA Death SAP MILD 
< 45  (27) 4 2 21 
> 45 (23) 4 8 11 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.047   -   
Significant 
Blood Urea > 40mg/dl is significantly associated with an 
increased mortality & severity 
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TABLE – 9 
 CREATININE  VS SEVERITY 
 
Creatinine Death SAP MILD 
< 2.0  (38) 5 5 28 
> 2.0  (12) 3 5 4 
 
            Death + SAP  Vs  Survival    ‘p’ value  =  0.028   -   
Significant 
Serum Creatinine  >2.0 mg/dl  is found to have statistically 
significant association with mortality and severity. 
 
 
TABLE – 10 
PaO2 VS SEVERITY 
PaO2 Death SAP MILD 
< 60 (7) 7 0 0 
> 60 (43) 1 10 32 
 
Death + SAP  Vs  Survival    ‘p’ value  =  < 0.001   -  
Significant 
Hypoxia marked by PaO2< 60mm Hg   is significantly 
associated with an increased  mortality & severity 
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TABLE – 11  
LDH VS SEVERITY 
 
LDH Death SAP MILD 
< 350  (39) 3 7 29 
> 350  (11) 5 3 3 
 
Death + SAP  Vs  Survival    ‘p’ value  =  0.012   -  Significant 
Serum LDH> 350U/L is found to have statistically significant 
association with mortality and severity. 
 
TABLE – 1 2 
BILIRUBIN  VS SEVERITY 
 
Bilirubin Death SAP MILD 
<  2  (43) 5 10 28 
> 2   (7) 3 0 4 
 
     Death + SAP  Vs  Survival    ‘p’ value  =  0.986   -  Not 
Significant 
With a cut off value of 2mg/dl  the difference in the bilirubin 
levels between      two groups (Death+SAP Vs Mild) were not 
statistically significant. 
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Table :13 
RANSON’S SCORE 
 
 Total N = 
50 
Death : 8 > 7 days / 
SAP 
< 7 days 
≥3 16 8 7 1 
< 3 34 0 3 31 
 
A total of 16 patients had Ranson’s score ≥ 3 which included  
15 patients of severe pancreatitis(including death) & 1 patient with 
mild pancreatitis. 
 
Table :14 
 Mortality Severity  
Sensitivity 8 / 8+0×100  = 100 15/15+3×100  = 83.33 
Specificity 34/34+8×100  = 80.95 31 / 31+1×100  = 96.8 
PPV 8 / 8+8 ×100 = 50 15/15+1×100  = 93.75 
NPV 34 / 34+0 ×100 = 100 31 / 31+3×100  =91.8 
 
Ranson’s Score has 100% sensitivity and 80.95% specificity in 
predicting Mortality.Sensitiviy and Specicificity in Predicting 
Severity is 83.33% and 96.8% respectively 
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Table :15 
APACHE II 
 Total N = 
50 
Death : 8 > 7 days / 
SAP 
< 7 days 
 >8 15 8 6 1 
< 8 35 0 4 31 
 
A total of 15 patients had APACHE II score >8 which 
included  14 patients of severe pancreatitis(including death) & 1 
patient with mild pancreatitis. 
 
Table :16 
 
 Mortality Severity  
Sensitivity 8 / 8+0×100  = 100 14/14+4×100  = 77.78 
Specificity 35/35+7×100  = 83.33 31 / 31+1×100 = 96.88 
PPV 8 / 8+7×100  = 53.33 14/14+1×100  = 93.33 
NPV 35 / 35+0×100  = 100 31 / 31+4×100  =88.57 
 
APACHE II  Score has 100% sensitivity and 83.33% 
specificity in predicting Mortality.Sensitiviy and Specicificity in 
Predicting Severity is 77.78% and 96.8% respectively. 
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Table 17 
Imries 
 
 Total N = 
50 
Death : 8 > 7 days / 
SAP 
< 7 days 
> 3 10 6 4 0 
< 3 40 2 6 32 
 
A total of 10 patients had Imrie’s score ≥ 3 which and all of 
them had severe pancreatitis. No patient with mild pancreatitis had a 
score≥3 
Table : 18 
 
 Mortality Severity  
Sensitivity 6 / 6+2 ×100 = 75 10/10+8×100  = 55 
Specificity 38/38+4×100  = 90.48 32 / 32+0×100  = 100 
PPV 6 / 6+4 ×100 = 60 10/10+0×100  =100 
NPV 38 / 38+2 ×100 = 95 32 / 32+8×100  = 80 
 
Imrie’s Score has 75% sensitivity and 90.48% specificity in 
predicting Mortality.Sensitiviy and Specicificity in Predicting 
Severity is 55% and 100% respectively 
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Table :19 
Bank’s Scores 
 
 Total N = 
50 
Death : 8 > 7 days / 
SAP 
< 7 days 
> 1 25 8 6 11 
< 1 25 0 4 21 
 
A total of 25 patients had Bank’s score ≥ 1which included  14 
patients of severe pancreatitis(including death) & 11 patient with 
mild pancreatitis. 
 
Table:20  
 Mortality Severity  
Sensitivity 8 / 8+0×100  = 100 14/14+4×100  = 77.78 
Specificity 25/ 25+17×100  = 59.52 21 / 21+11×100  = 65.63 
PPV 8 / 8+17×100  = 32 14/14+11×100  =56 
NPV 25 / 25+0×100  = 100 21 / 21+4×100  = 84 
 
Bank’s Score has 100% sensitivity and 59.52% specificity in 
predicting Mortality.Sensitiviy and Specicificity in Predicting 
Severity is 77.78% and 65.63% respectively 
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Table:21 
Pitchumani & Agarwal Score 
 
 Total N = 
50 
Death : 8 > 7 days / 
SAP 
< 7 days 
> 1 20 8 3 9 
< 1 30 0 7 23 
 
A total of 20 patients had Pitchumani score ≥ 1which included  
11 patients of severe pancreatitis(including death) & 9 patient with 
mild pancreatitis. 
 
Table :22 
 Mortality Severity  
Sensitivity 8 / 8+0×100 = 100 11/11+7 ×100 = 61.11 
Specificity 30/30+12×100  = 71.43 23 / 23+9×100  = 71.88 
PPV 8 / 8+2×100  = 40 11/11+9×100  =55 
NPV 30 / 30+0×100  = 100 23 / 23+7×100  = 76.67 
 
Pitchumani and Agarwal Score has 100% sensitivity and 
71.43% specificity in predicting Mortality.Sensitiviy and 
Specicificity in Predicting Severity is 61.11% and 71.88% 
respectively. 
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Table:23 
Comparison of Scoring systems in predicting Mortality 
 
 Sensitivity Specificity PPV NPV 
Apache II 100% 83.33% 57.33 100 
Ransons 100% 80.95% 50 100 
Imrie 75% 90% 60 95 
Banks 100% 59.52% 32 100 
Pitchumani 100% 71.43% 40 100 
 
 
     Table:24 
Comparison of Scoring systems in predicting Severity 
 
 Sensitivity Specificity PPV NPV 
Apache II 77.78% 96.88% 93.33 88.57 
Ransons 83.33% 96.88% 93.75 91.18 
Imrie 55% 100% 100 80 
Banks 77.78% 65.63% 56 84 
Pitchumani 61.11% 71.88% 55 76.67 
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     Table :25 
Comparison of performance APACHE II system in various 
studies in predicting severity 
 
 Our study Papachriston 
Et al10 
Wilson C 
Et al 32 
Larvin et 
al41 
Marco 
Simoe51 
Sensitivity 77.78% 70.3% 82% 77% 79.4% 
Specificity 96.88% 71.9% 74%  83.1% 
 
      
Table :26 
 
Comparison of performance of Ranson’s system in various 
studies in predicting severity 
 
 Our Study Papachriston 
Et al10 
Sternberg44 Marco 
Simoe51 
Sensitivity 83.33% 84.2% 72% 91.2% 
Specificity 96.8% 89.8% 76% 71.4% 
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Table :27 
 
Comparison of Performance of Imrie’s system in various 
studies in predicting severity 
 
 Our Study Barreto 
Et al6 
Sternberg44 Marco 
Simoe51 
Sensitivity 55% 56% 63% 73.5% 
Specificity 100% 98% 84% 71 % 
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DISCUSSIONS 
 
 In this study we compared the accuracy of five representative 
prognostic multi factorial scoring systems in acute pancreatitis.  We 
also assessed the accuracy of 12 individual parameters in assessing 
the severity / mortality of acute pancreatitis. 
 50 patients with acute pancreatitis were enrolled in our study.  
Among this 42 were males and 8 were females.  
 In this 50 patients, 8 patients died ie the mortality rate was  
16%.  A total of 18 patients (including dead patients) were found to 
have severe acute pancreatitis (SAP). 
               On assessing the individual variable, we found that 
there was statistically significant difference exist between severe 
pancreatitis and mild pancreatitis in the case of seven variables. 
They include 
 1. PaO2 -           ‘p’ value   <  0.001 
 2. Blood Urea - ‘p’ value   0.047 
 3. Sr.creatinine- ‘p’ value    0.028 
 4. Sr. Calcium - ‘p’ value    0.048 
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 5. Total count - ‘p’ value    < 0.001 
 6. LDH   - ‘p’ value   0.012 
 7. Age  - ‘p’ value    0.046 
In a study conducted by Blamy et al19, they found that 
Sr.Creatinine  of > 2.0 mg/dl is associated with severity. Fan31 and 
coworkers  also suggested that isolated serum urea elevation could 
predict SAP. Similiar finding were alsoobserved in studies by Lautz et 
al38, Haxiaobieke Kasimu et al15, Sournitra R Ecachempali3 et al. 
 In our study hypoxia ie PaO2 <60mm Hg is also found out be 
a strong predictor of SAP.Similiar observations were made by 
Sournitra Ecachempali3 et al. 
 Hypocalcemia also was found to be a predictor of severity of 
pancreatitis in our study.This is correlating with the various studies by  
Bechien.WU et al57, Cooper MJ et al55, Sournitra R Ecachempali3 et al. 
 Serum LDH levels also showed a significant difference 
between mild and severe acute pancreatitis.Similiar observations 
were made by Kaya E et al49, Chen C-C et al45. 
 Leukocytosis which is considered as a marker of SIRS is also 
an independent predictor of SAP.With a cut off value of >15000 it 
also showed a significant difference between Mild and Severe 
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pancreatitis.Similiar findings were observed by Lautz et al38, 
Haxiaobieke Kasimu et al15. 
               Hemoconcentration marked as an increase in PCV is 
generally considered as a marker of  severity. In our study none of 
the patients had PCV more than 44.This is not correlating with the 
various literature. 
 On analyzing various scoring system, a Ranson’s score ≥ 3,  
Apache II > 8,  Imrie score ≥ 3, Banks score ≥ 1, Pitchumani & 
Agarwal score ≥ 1 were taken as predictor of severe pancreatitis. 
Apache II Score : 
 Among 50 patients, 15 patients had an Apache II score of >8.  
It included all the dead patients ,that means Apache II had 100% 
sensitivity in predicting mortality with a negative predictive value of 
100.  Its specificity was 83.33% of positive predictive value was 
53.33%. 
 This results corresponds to the results of Papachisto et10 al 
were they found that Apache II has a 100% sensitivity in predicting 
mortality. 
 A total of 18 patients had severe acute pancreatitis (including 
death patients). In this 14 patients had Apache II > 8,  among 
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patients with mild pancreatitis only one had Apache II score of >8.  
Thus on predicting severity Apache II had a sensitivity of 77.78%, 
specificity of 96.88%, PPV of 93.33 and NPV of 88.57. 
 Wilson C et al32, in their study found that Apache II has a 
sensitivity of 82%, specificity of 74%. 
 Study by Larvin et al41 also showed that Apache II has a 
sensitivity of 77% at the time of admission. 
 Papachriston et10 al in their study also showed that Apache II 
has a sensitivity of 70.3% and specificity of 71.9%. 
Marco Simoe et al51 in their study showed that APACHE II  system 
has 
   
Sensitivity of  79.4%    and specificity of   83.1%    in predicting severity. 
 
 In our study, the sensitivity very much matches with these 
studies, and the specificity in our study was more than what we 
found in many other studies. 
Ranson’s Score : 
 Among 50 patients, 16 had a Ranson’s score ≥ 3, Among them 
8 patients died 7 had other evidences of SAP and 1 had mild 
pancreatitis that means all the dead patients had a Ranson’s score of 
63
   
≥ 3.  ie. It has a 100% sensitivity in predicting mortality as we have 
seen with Apache II.  The specificity was 80.95%. 
 In predicting the severity as a whole its sensitivity was 83.33% 
specificity of 96.8% PPV of 93.15 and NPV of 91.18. 
 In similar study, Georgios L. Papachriston et10 al showed that 
the sensitivity of Apache II in predicting the mortality is 100% as we 
have seen in our study. While the sensitivity in predicting the 
severity was 84.2% and specificity was 89.8% which is very much 
similar to our study. 
  In a study by Steinberg44  Ranson criteria have an estimated  
sensitivity of 72%  and  specificity of 76%. 
  Marco Simoe et al51 in their study showed that Ransons system  
has a sensitivity of   91.2%  and specificity of   71.4%  in predicting 
severity. 
 A meta analysis encompassing 1,300 patents reported that 
Ranson’s has an overall sensitivity of 75% and specificity of 77%. 
Imrie’s Scoring system : 
 Using a cut off of ≥ 3 as severe pancreatitis, Imries scoring 
system predicted severe pancreatitis in 10 out of 50 patients. 
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Death patients - n = 8 -   among this 6 had Imrie  score ≥ 3 
SAP other than Death- n = 10 – Among this 4 had Imrie score ≥ 3 
Mild pancreatitis - n = 32 -  Among this none had score ≥3 
 With this data we found that Imries system has a sensitivity of 
75, specificity of 90.48%, PPV of 66 and NPV of 95 in predicting 
mortality. 
 For assessing the severity it has a sensitivity of 55%, 
specificity of 100%, PPV of 100 and NPV of 80.  Our study is very 
much comparable to the study Berreto et al6 done in Goa Medical 
College, India were they found that Imries system has a sensitivity 
of 56%, specificity of 98%, PPV 94%  and NPV of 80%. 
 Marco Simoe et al51 in their study showed that Imrie’s 
system hassensitivity of  73.5% and specificity of   71.1%    in  predicting 
severity. 
      In a study by Steinberg44  Imrie’scriteria have an estimated  
sensitivityof 63% and  specificity of 84%. 
 
      But when the scoring system was originally proposed by SL 
Blamey, CW. Imrie in 1986, it predicted severity correctly in 79% 
cases19. 
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Bank’s Scoring system : 
 A bank’s score ≥ 1 was taken as a predictor of severe acute 
pancreatitis.  With this cut off it predicted SAP in 25 out of 50 
patients. 
 Death – 8 patients – all of them had Bank’s score ≥1 
 Severe Acute pancreatitis (excluding death) Æ 10 patients 
  6 of them had score ≥1 
 The sensitivity in predicting the mortality was 100% while the 
specificity was only 59.52%.  On predicting severity sensitivity was 
77.77%, specificity was 65.63%. 
Pitchumani and Agarwal Score : 
 A score ≥1 was taken as predictor of severe acute pancreatitis 
with this 20 out of 50 patients were predicted to have SAP. 
 Death   -    n = 8 All of them had Score ≥1 
 SAP    -    n = 10  -   3 had Score  ≥ 1 
 Mild    -    n = 32  -   9 had score ≥1 
 In predicting mortality sensitivity was 100%, specificity was 
71.45%. 
 In predicting severity it had a sensitivity of 61.11%, specificity 
of 71.88%. 
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 On comparing the different scoring systems, we found that in 
predicting mortality, Apache II, Ranson’s, Bank’s, Pitchumani 
scoring systems had 100% sensitivity while the maximum specificity 
was for Imries. 
 But for predicting the severity compared Apache II, Ranson’s 
system, performed well with a sensitivity of 83.33% and specificity 
of 96%.  Imries system was highly specific but its sensitivity was 
quite low.  Both Bank’s system and Pitchumani and Agarwal scoring 
system has relatively low sensitivity and specificity. 
         The APACHE II System seems to be superior to other systems 
because it is the only system which takes in to account  of all the 
major risk factors that predict outcome from the disease including 
the acute physiological changes as well as the patient’s ability to 
recover which may be diminished by advancing age and chronic 
diseases. 
    Our study also showed that still now Ranson’s score remains 
valid for predicting the severity and mortality of acute pancreatitis. It 
was proved to be equally efficient when compared  to the rather 
complex APACHE II system in predicting SAP. 
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CONCLUSION 
1. Evidence of end organ dysfunction marked by hypoxia and 
acute renal failure are highly sensitive predictors of severity 
and mortality of acute pancreatitis. 
2. Advancing age, leukocytosis, hypocalcemia and increase in 
LDH levels were the other factors found to be significant in 
predicting  severity of acute pancreatitis in our study. 
3.  Ranson’s scoring system was found to be the best to 
predict the outcome in acute pancreatitis compared to 
Apache II in our study. 
4. Imrie scoring system even though highly specific it is less 
sensitive in predicting outcome in our study. 
5. Bank’s system and Pitchumani and Agarwal scoring system 
had low sensitivity and specificity. 
6. The limitations of these scoring systems could be that they 
converted continuous variables to binary variables of equal 
weight and thus failing to capture synergistic effects based 
on the interaction of inter dependent   systems. 
68
   
7. Future researches could focus on the incorporation of pre-
existing risk factors and novel accurate biomarkers into the 
scoring systems. 
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LIMITATIONS OF THE STUDY 
 
1. Sample size in our study is relatively small. 
2. The aetiology of pancreatitis was not considered in our 
study. 
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SUMMARY 
A prospective, observational study was conducted in 50 
patients admitted with acute pancreatitis in Government Rajaji 
Hospital Madurai. The aim of the study was to compare the strength 
of various parameters in predicting the severity of acute pancreatitis 
and to compare the performance of various scoring systems 
predicting the mortality and severity of acute pancreatitis. On 
analyzing the final results we found that Ranson’s scoring system  
and Apache II system were the best systems in predicting the 
mortality and severity of acute pancreatitis. Among individual 
parameters hypoxia, renal failure, advancing age, leukocytosis, 
hypocalcemia and increase in LDH levels were associated with 
increased severity of acute pancreatitis. 
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A Study on the profile of various scoring systems in assessing the severity of acute pancreatitis 
Name:    Age: Sex: 
Presenting complaints:    Alcoholic: 
GCS Pulse Rate B.P Respiratory 
Rate 
Temperature Comorbidity 
      
 
Investigations 
PCV  S.Amylase  S.Bilirubin  USG Abdomen 
TC  S.Calcium  AST   
PLC  S.Albumin  ALT  CT Abdomen 
PaO2  Blood Urea  LDH   
HCO3-  S.Creatinine  RBS  Fluid sequestration 
 
Scores 
APACHE II Ranson’s Imries Banks Pitchumani 
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1 Shanmuganathan 65 M 90/70 32 12 30 17400 2.1 54% 612 106 2.9 6.6 4.5 59 49 373 18 1
2 Mahalingam 47 M 100/80 36 13 31 15300 99000 52% 456 460 0.9 8.1 4.2 21 53 750 132 2
3 Sivakumar 56 M 90/60 26 15 36 15500 1.3l 59.50% 1116 480 1 7.9 4.8 62 98 850 103 3
4 Baskaran 32 M 110/70 28 15 30 17900 1.6L 58% 846 108 2.2 8.2 3.9 286 302 410 86 4
5 Ramdoss 48 M 120/80 34 15 24 19070 1.2l 52 555 48 0.9 7.1 3 34 22 420 17 5
6 Periyakaruppan 35 M 96/60 32 14 40 13300 100000 50 566 112 0.8 7.8 3.1 320 344 365 30 6
7 Bhoomi 60 M 80/70 22 14 33 12500 78000 65% 330 84 2.1 7.8 3.1 376 360 280 24 7
8 Thavasi 62 M 110/70 30 15 34 18200 2.2L 56% 724 356 1.3 8.4 4.2 120 98 165 146 8
9 Muthukon 58 M 100/60 20 15 30 11200 1.1l 68% 448 120 0.8 7.5 3 56 78 180 88 9
10 Vijayan 56 M 130/80 20 15 31 11200 2.4L 72% 656 112 1 7.4 4.3 88 38 408 102 10
11 Palani 62 M 126/70 26 15 32 15660 88000 70% 342 256 1.8 8.4 3.8 224 312 112 112 11
12 Ayyanar 35 M 116/80 16 15 41 4500 3.2L 56% 512 98 1 7.1 5.5 65 80 240 123 12
13 Arasan 58 M 90/60 18 15 36 15420 4L 68% 646 208 0.9 8.2 4.8 78 45 389 56 13
14 Muthusamy 50 M 100/60 18 15 31 6330 1.1L 70% 387 121 0.8 8.9 5 86 64 210 50 14
15 Ramakrishnan 56 M 110/80 22 15 30 7200 1.6L 65% 442 229 1 8 4.8 42 28 412 112 15
16 Pavunraj 60 M 96/60 24 15 38 16680 90100 70% 586 98 1.1 7.3 3.1 112 89 121 24 16
17 Ramayee 48 F 100/80 22 15 62 6800 4.1L 72% 360 105 1 8 4.2 45 23 408 30 17
18 Mani 50 M 120/80 16 15 32 9600 2.5L 68% 286 110 1.1 8.4 4.5 32 28 128 48 18
19 Abdulla 35 M 130/80 14 15 38 4200 3.5L 74% 312 154 0.8 7.8 4.2 21 18 98 16 19
20 Arumugam 36 M 140/80 12 15 38 5600 3.9L 74% 778 80 0.8 7.1 4.6 27 28 110 84 20
21 Maniraj 46 M 120/70 16 15 32 9200 2.8L 68% 230 84 0.9 7.5 5.4 42 62 140 25 21
22 Saravanamuthu 43 M 118/60 12 15 52 5800 2.1L 70% 263 110 0.8 8.4 4.5 336 426 96 34 22
23 Annadurai 38 M 138/90 14 15 33 7200 2.6L 64% 446 96 1 8.1 4 46 56 156 56 23
24 Sivalakshmi 46 F 112/79 15 15 36 5800 1.9L 68% 447 68 0.8 8.2 5.8 17 20 53 17 24
25 Palraj 22 M 120/80 13 15 34 9000 4.3L 71% 462 123 1.2 8.1 3 21 46 146 21 25
26 Subramaniam 56 M 120/70 11 15 30 12000 1.8L 72% 322 140 0.8 8.8 4 229 229 110 48 26
27 Matchakalai 35 M 118/90 10 15 32 7200 2.0L 70% 1404 86 2.2 8 4.5 196 145 127 25 27
28 Duraipandi 35 M 112/70 18 15 36 6200 1.9L 72% 767 102 2.8 8.6 4.5 82 65 180 24 28
29 Sundaresan 30 M 110/70 16 15 33 5200 3.4L 66% 289 79 1.2 8 3.8 21 25 108 32 29
30 Bhuvaneshwari 42 F 140/90 17 15 42 4600 2.2l 70% 382 110 1 8.2 4 42 36 428 28 30
31 Palanivel 29 M 150/90 14 15 44 4100 2.6l 72% 347 146 3 7 3.1 45 21 386 23 31
32 Muthukrishnan 52 M 120/80 13 15 30 6000 3.4l 68% 426 125 1 8.4 4.5 62 48 189 46 32
33 Rahman 36 M 118/60 12 15 36 4800 4l 64% 560 90 0.8 8.4 5.2 36 29 140 56 33
34 Ramalakhmi 48 F 120/80 16 15 32 5110 1.9L 72% 496 146 0.8 8.1 3.9 46 36 196 96 34
35 Sundar 42 M 150/100 17 15 33 6700 3.4L 70% 296 161 1 9 5.5 65 46 234 116 35
36 Raja 34 M 130/80 12 15 40 6200 2.8L 72% 280 154 1 9 4.5 41 30 124 26 36
37 Palaniyandi 38 M 120/80 20 15 34 4680 3.3L 67% 223 93 0.8 8 3.5 320 321 90 18 37
38 Panchavarnam 56 F 120/60 14 15 30 8200 1.8L 70% 679 202 1 8.1 4.5 46 64 126 39 38
39 Thevanesam 42 M 120/60 17 15 33 10200 1.6L 67% 356 110 2.6 8.2 3.9 286 268 110 26 39
40 Rajaram 37 M 110/70 13 15 36 11000 4.1L 70% 421 90 1 7.6 3 45 28 100 48 40
41 Karupusamy 32 M 130/90 21 15 40 5200 2.2L 64% 650 225 1 8 3.8 36 46 390 28 41
42 Selvi 60 F 130/100 12 15 33 4790 2.9L 68% 268 89 1.1 8.2 4.8 56 26 120 48 42
43 Jeyalakshmi 63 F 110/80 14 15 36 5600 4.1L 72% 330 120 1 8.1 5.5 84 76 150 86 43
44 Anthoniammal 42 M 110/90 17 15 33 5270 3.3L 68% 268 110 0.9 8 5.4 25 16 90 34 44
45 karuthagoundar 28 M 140/90 18 15 40 4600 3.1L 72% 332 96 1 8.6 4.4 46 46 108 30 45
46 Andy 39 M 140/90 9 15 36 4870 2.1L 68% 423 78 1.1 8 4.5 68 87 119 46 46
47 Pandian 36 M 112/80 12 15 33 5280 1.8L 70% 225 90 1 8.1 5 56 36 157 35 47
48 Kalpana 57 F 120/80 10 15 40 7400 2.1L 66% 345 108 0.9 8.4 3.1 76 56 118 26 48
49 Sureshkumar 61 M 110/90 16 15 38 6580 2.8L 68% 280 208 1.1 8 4.6 66 25 256 38 49
50 Kumar 36 M 118/60 12 15 36 4800 4l 64% 560 90 0.8 8.4 5.2 36 29 140 40 50
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0.9 3 4L 134 3.3 DEATH 4 4 2 2 12
3.8 2 3.5L 126 3.5 DEATH 4 4 3 2 18
2.8 3 4L 135 4 DEATH 5 5 3 2 15
1.4 3 3.5L 145 4.4 DEATH 3 2 2 2 15
0.5 2 3.5L 130 4.2 DEATH 3 3 2 2 15
0.9 2 4L 127 4.1 DEATH 3 3 2 2 14
0.8 3 5L 138 3.7 DEATH 4 3 2 2 14
2.6 2 3L 125 5.4 DEATH 3 2 2 1 15
2 1 3L 120 5.3 >7DAYS 3 3 2 2 8
2.5 0 3.5L 138 4.2 >7DAYS 3 3 2 1 8
3.8 0 3L 142 5.2 >7DAYS 3 3 1 0 8
3.6 1 3L 132 4.8 >7DAYS 3 3 1 0 8
1.1 1 3L 130 4.3 >7DAYS 3 2 1 0 8
0.9 0 3.5L 133 3.6 >7DAYS 0 0 0 0 4
2.8 1 3.5L 142 5.8 >7DAYS 3 2 0 0 8
1 0 3L 128 3.6 >7DAYS 3 2 1 1 5
1.1 0 4L 134 3.1 >7DAYS 1 0 0 0 4
1.2 0 2.5L 129 5.6 >7DAYS 0 0 0 0 5
0.7 0 2L 134 4.6 <7DAYS 1 1 1 1 4
3.1 0 3L 141 4.7 <7DAYS 2 2 2 1 4
0.8 0 2.5L 140 4.1 <7DAYS 1 1 1 1 4
1.1 0 3L 129 5.5 <7DAYS 1 1 0 0 1
1.6 0 3L 139 5.2 <7DAYS 0 0 0 0 3
0.7 0 3L 130 5.1 <7DAYS 0 0 0 0 2
0.8 0 3.5L 133 5 <7DAYS 1 1 1 1 1
1.2 0 2.5L 127 4.8 <7DAYS 0 0 0 0 6
0.9 0 2.5L 143 4.9 <7DAYS 0 0 0 0 0
0.7 0 3L 136 4.8 <7DAYS 0 0 0 0 0
1.2 0 2.5L 132 4.5 <7DAYS 0 0 0 0 1
0.6 0 3L 137 5.1 <7DAYS 0 0 0 0 0
0.8 0 3L 145 4.1 <7DAYS 3 2 1 1 0
1.2 0 3L 128 5.2 <7DAYS 0 0 0 0 3
1 0 3.5L 142 3.7 <7DAYS 0 0 0 0 1
3.4 0 2L 133 5.3 <7DAYS 1 1 1 1 5
3.9 0 3L 143 5.1 <7DAYS 1 1 1 1 8
0.9 0 3L 126 3.9 <7DAYS 0 0 0 0 1
0.7 0 3.5L 137 4 <7DAYS 1 1 0 0 1
1.1 0 3.5L 143 4.2 <7DAYS 1 1 0 0 3
0.6 0 3L 142 4.2 <7DAYS 1 1 0 0 0
1.4 0 3L 127 4 <7DAYS 2 2 2 1 0
0.8 0 2L 136 3.6 <7DAYS 2 1 0 0 0
1.4 0 2.5L 129 3.9 <7DAYS 0 0 0 0 2
2.6 0 2L 131 5.2 <7DAYS 1 1 1 1 6
1.1 0 3L 142 4.8 <7DAYS 0 0 0 0 1
1 0 3.5L 126 4 <7DAYS 0 0 0 0 1
1.4 0 3L 138 5 <7DAYS 0 0 0 0 1
1 0 3L 140 5.1 <7DAYS 0 0 0 0 1
0.9 0 2.5L 139 3.7 <7DAYS 1 1 1 0 2
1.2 0 2.5L 140 3.8 <7DAYS 1 1 0 0 2
1 0 3.5L 142 3.7 <7DAYS 0 0 0 0 1
